A leading pharmaceutical company faced rising cyberattacks targeting research patents and trade secrets, including sophisticated zero-day threats. Their siloed endpoint and security monitoring tools produced low-fidelity alerts without sufficient context, making investigations slow and manual and increasing the risk of data breaches. To address these challenges, the company integrated Securonix with Tanium, enabling advanced analytics and real-time endpoint visibility. This unified approach improved threat detection, prioritized alerts effectively, and strengthened protection for vulnerable endpoints across the organization.

Join for free to read